Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling
about
Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated CardiotoxicityThe Role of p38 MAPK in the Development of Diabetic CardiomyopathyThe Role of ERK1/2 in the Development of Diabetic CardiomyopathyAngiotensin-converting enzyme 2 overexpression protects against doxorubicin-induced cardiomyopathy by multiple mechanisms in rats.Schisandrae Fructus Reduces Symptoms of 4-Vinylcyclohexene Diepoxide-Induced Ovarian Failure in Mice.Effects of Polyphenols on Oxidative Stress-Mediated Injury in Cardiomyocytes.Schisandrin B attenuates the inflammatory response, oxidative stress and apoptosis induced by traumatic spinal cord injury via inhibition of p53 signaling in adult ratsSchisandrin B Prevents Hind Limb from Ischemia-Reperfusion-Induced Oxidative Stress and Inflammation via MAPK/NF-κB Pathways in Rats.The herbal formula KH-204 is protective against erectile dysfunction by minimizing oxidative stress and improving lipid profiles in a rat model of erectile dysfunction induced by hypercholesterolaemiaCurrent knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: a review on the bioactive components, pharmacological properties, analytical and biotechnological studies.Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism.Simultaneous Qualitative and Quantitative Analysis of Multiple Chemical Constituents in YiQiFuMai Injection by Ultra-Fast Liquid Chromatography Coupled with Ion Trap Time-of-Flight Mass Spectrometry.Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways.Schisandrin B reverses doxorubicin resistance through inhibiting P-glycoprotein and promoting proteasome-mediated degradation of survivin.Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles.Schisandra chinensis Stem Ameliorates 3-Nitropropionic Acid-Induced Striatal Toxicity via Activation of the Nrf2 Pathway and Inhibition of the MAPKs and NF-κB Pathways.Reappraisal of metallothionein: Clinical implications for patients with diabetes mellitus.Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions.Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts.Antioxidant and Protective Effects of Schinus terebinthifolius Raddi Against Doxorubicin-Induced Toxicity.Comparative Phytochemical Analysis of Chinese and Bay Starvine (Schisandra spp.): Potential for Development as a New Dietary Supplement Ingredient.Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 Upregulation.Schizandrin B inhibits the cis‑DDP‑induced apoptosis of HK‑2 cells by activating ERK/NF‑κB signaling to regulate the expression of survivin.Suppression of P2X7/NF-κB pathways by Schisandrin B contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury.Forskolin attenuates doxorubicin-induced accumulation of asymmetric dimethylarginine and s-adenosylhomocysteine via methyltransferase activity in leukemic monocytes.Nrf2-dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicin-induced cardiotoxicity
P2860
Q26744634-6CDCA4AB-0B9F-494A-8446-360C4AAF3D12Q26744743-8037A0B3-B440-4ACC-97CF-44A959C28314Q28075539-9303B45D-AA0A-49D4-B777-DC43DA7B8296Q33648557-35F33FA0-07F4-4065-8959-4C49E219B1B6Q33726316-3C9765D4-5C3B-4414-960E-37BD99A383A3Q33749642-13541917-3ACE-461F-B6BA-D05C78D547ABQ33828088-E06901D4-FFDD-41BC-ABFC-EA2C81D7707BQ33863625-ACF742E9-E37A-4A71-AE7A-E5090D9A5D56Q36290446-15A8A0B7-02D5-4187-B632-0355E20F6750Q37736045-CD4ADFBF-82EE-45DD-BB00-AD99C516F5A2Q38779463-DEE31938-FA6A-481A-9F7C-3012AC1D7B40Q39744532-2DD2554D-2C61-4730-A835-2ABEEE4FAC8DQ41200548-59A840ED-C43F-4E2B-9D73-386736581071Q41489534-36B49AA2-FCE0-4E25-906A-E87D27665B06Q42280481-82ECB069-DF6F-468E-8E11-DB3043BFBDDDQ42369993-4E2517BA-5113-478D-BCAE-0EEACF2C982AQ46274356-67859E29-001A-489E-A0A5-BE6F1ABACEE5Q46280777-A281305D-9DF5-4BB1-B7AB-CB55411BFF75Q46304110-C420855F-82DA-4C9B-9BBC-C43F1A850459Q46309547-811F67A5-BF52-4E7C-896B-EA92D8B1632AQ46388926-4E73067A-6A74-494D-8973-635D82B1CC3BQ48245077-03A9AAAF-38B3-4FD5-8FED-A005F3CD2520Q49380007-C10EAB7A-1760-4CC5-BF9A-623E7FB72E4EQ53188118-120D69C7-085B-4ACF-8E2B-D70B57FABDD2Q54985792-4403B95A-90AC-43A6-A642-10E03DD223F7Q58767703-409CDE0F-3DF7-4C2F-A6B0-775EA649C4A6
P2860
Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Schisandrin B prevents doxorub ...... hibition of MAPK/p53 signaling
@ast
Schisandrin B prevents doxorub ...... hibition of MAPK/p53 signaling
@en
Schisandrin B prevents doxorub ...... hibition of MAPK/p53 signaling
@nl
type
label
Schisandrin B prevents doxorub ...... hibition of MAPK/p53 signaling
@ast
Schisandrin B prevents doxorub ...... hibition of MAPK/p53 signaling
@en
Schisandrin B prevents doxorub ...... hibition of MAPK/p53 signaling
@nl
prefLabel
Schisandrin B prevents doxorub ...... hibition of MAPK/p53 signaling
@ast
Schisandrin B prevents doxorub ...... hibition of MAPK/p53 signaling
@en
Schisandrin B prevents doxorub ...... hibition of MAPK/p53 signaling
@nl
P2093
P2860
P3181
P1433
P1476
Schisandrin B prevents doxorub ...... hibition of MAPK/p53 signaling
@en
P2093
Kam Ming Ko
Kenichi Watanabe
Kenji Suzuki
Rajarajan A Thandavarayan
Somasundaram Arumugam
Tetsuya Konishi
Vijayasree V Giridharan
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0119214
P407
P577
2015-03-05T00:00:00Z